Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña





World News Moderna To Deliver Covid 19 Vaccine To Hard Hit Developing World The Wall Street Journal

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, World News Moderna To Deliver Covid 19 Vaccine To Hard Hit Developing World The Wall Street Journal is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


World News Moderna To Deliver Covid 19 Vaccine To Hard Hit Developing World The Wall Street Journal | RobinsPost News & Noticias

We can stop COVID-19: Moderna vaccine success gives world more hope


Moderna Inc's experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report ... Read More

Moderna CEO expects COVID-19 vaccine interim results in November - WSJ


Moderna Inc Chief Executive Officer Stéphane Bancel expects interim results from its COVID-19 vaccine trial in November and that the U.S government could give an emergency use nod in December, the ... Read More

Moderna to charge $25-$37 for COVID-19 vaccine - CEO tells paper


Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag ... Read More

-Moderna to seek limited emergency use of COVID-19 vaccine if data shows high efficacy


If Moderna Inc's COVID-19 vaccine proves to be at least 70% effective, the company plans to seek emergency authorization for its use in high-risk groups, the company's chief executive told Reuters. Read More

Moderna: Next-gen COVID shot prompts strong immune response


Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ... Read More

World should not be complacent after COVID-19 vaccine news - WHO


The World Health Organization (WHO) welcomed Moderna reporting on Monday that its experimental vaccine showed 94.5% efficacy but said that "many questions" remained and it was no time for complacency. Read More

EU secures 160 mln doses of Moderna's COVID-19 vaccine


The European Union has struck a deal for up to 160 million doses of U.S. firm Moderna's COVID-19 vaccine candidate, the head of the European Commission said on Tuesday, taking the EU's potential stock ... Read More

Moderna COVID-19 vaccine stability eases distribution challenges


Moderna Inc's experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage ... Read More

-Vaccine developer Moderna could slow COVID-19 trials to add at-risk minorities


Moderna Inc has been asking sites that are conducting clinical trials of its experimental coronavirus vaccine to focus on enrolling at-risk minorities, even if that slows down the trial speed, the ... Read More

Moderna to supply 4 mln more doses of COVID-19 vaccine to Israel


Moderna Inc said on Friday it has extended its contract with the Israeli health ministry to supply an additional 4 million doses of its COVID-19 vaccine candidate. Read More

COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval


Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus